A spontaneous acinar cell carcinoma model for monitoring progression of pancreatic lesions and response to treatment through noninvasive bioluminescence imaging

Clinical Cancer Research

Volumn 15, Issue 15, 2009, Pages 4915-4924

  Zhang, Ning ^a   Lyons, Scott ^b   Lim, Ed ^a   Lassota, Peter ^a  

^a Caliper Life Sciences   (United States)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN;

ACINAR CELL CARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; MALE; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; TRANSGENIC MOUSE; TUMOR GROWTH;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, ACINAR CELL; DISEASE MODELS, ANIMAL; DRUG MONITORING; LONGITUDINAL STUDIES; LUMINESCENT MEASUREMENTS; MICE; MICE, TRANSGENIC; PANCREAS; PANCREATIC NEOPLASMS; SIROLIMUS;

EID: 68049126414     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-2256     Document Type: Article

References (28)

1. Moore PS, Beghelli S, Zamboni G, Scarpa A. Genetic abnormalities in pancreatic cancer. Mol Cancer 2003;2:7.
2. Landies SH, Murray T, Bolden S, Wingo PA. Cancer statistics. J Am Cancer Soc 1999;49:8-31.
3. Hanahan D. Transgenic mice as probes into complex systems. Science 1989;246:1265-1275 (Pubitemid 20066709)
4. Bergers G, Javaherian K, Lo KM, Folkman J, Hanahan D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 1999;284:808-812 (Pubitemid 29291347)
5. Frese KK, Tuveson DA. Maximizing mouse cancer models. Nat Rev Cancer 2007;7:645-658
6. Klimstra DS. Nonductal neoplasms of the pancreas. Mod Pathol 2007;20 Suppl 1:S94-112.
7. Longnecker DS, Kuhlmann ET, Freeman DH, Jr. Characterization of the elastase 1-simian virus 40 T-antigen mouse model of pancreatic carcinoma: effects of sex and diet. Cancer Res 1990; 50:7552-7554
8. Tevethia MJ, Bonneau RH, Griffith JW, Mylin L. A simian virus 40 large T-antigen segment containing amino acids 1 to 127 and expressed under the control of the rat elastase- 1 promoter produces pancreatic acinar carcinomas in transgenic mice. J Virol 1997; 71:8157-8166 (Pubitemid 27446391)
9. Grippo PJ, Nowlin PS, Demeure MJ, Longnecker DS, Sandgren EP. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice. Cancer Res 2003;63:2016-2019
10. Contag CH, Spilman SD, Contag PR, et al. Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol 1997;66:523-531
11. Lyons SK, Lim E, Clermont AO, et al. Noninvasive bioluminescence imaging of normal and spontaneously transformed prostate tissue in mice. Cancer Res 2006;66:4701-4707
12. Lyons SK. Advances in imaging mouse tumour models in vivo. J Pathol 2005;205:194-205. (Pubitemid 40227991)
13. Bjornsti MA, Houghton PJ. The TOR pathway: a target for cancer therapy. Nat Rev Cancer 2004; 4:335-348 (Pubitemid 38579480)
14. Hidalgo M, Rowinsky EK. The rapamycinsensitive signal transduction pathway as a target for cancer therapy. Oncogene 2000;19:6680-6686 (Pubitemid 32197708)
15. Wislez M, Spencer ML, Izzo JG, et al. Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras. Cancer Res 2005;65:3226-3235 (Pubitemid 40524605)
16. Majumder PK, Febbo PG, Bikoff R, et al. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat Med 2004;10:594-601. (Pubitemid 38796850)
17. Liu M, Howes A, Lesperance J, et al. Antitumor activity of rapamycin in a transgenic mouse model of ErbB2-dependent human breast cancer. Cancer Res 2005;65:5325-5336 (Pubitemid 40827345)
18. Mabuchi S, Altomare DA, Connolly DC, et al. RAD001 (Everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer. Cancer Res 2007;67:2408-2413 (Pubitemid 46548923)
19. Ornitz DM, Hammer RE, Messing A, Palmiter RD, Brinster RL. Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice. Science 1987;238:188-193 (Pubitemid 17139719)
20. Hogan B. Manipulating the mouse embryo: a laboratory manual. 2nd ed. p. xvii, 497Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1994.
21. Fowlis DJ, Balmain A. Oncogenes and tumour suppressor genes in transgenic mouse models of neoplasia. Eur J Cancer 1993;29A:638-645 (Pubitemid 23036325)
22. Schneider G, Siveke JT, Eckel F, Schmid RM. Pancreatic cancer: basic and clinical aspects. Gastroenterology 2005;128:1606-1625 (Pubitemid 40692555)
23. Prasad NB, Biankin AV, Fukushima N, et al. Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells. Cancer Res 2005;65:1619-1626 (Pubitemid 40478583)
24. Vooijs M, Jonkers J, Lyons S, Berns A. Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice. Cancer Res 2002;62:1862-1867 (Pubitemid 34408514)
25. Zhu L, Shi G, Schmidt CM, Hruban RH, Konieczny SF. Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia. Am J Pathol 2007;171:263-273 (Pubitemid 47339243)
26. Warner SL, Muñoz RM, Bearss DJ, Grippo P, Han H, Von Hoff DD. Pdx-1-driven overexpression of aurora a kinase induces mild ductal dysplasia of pancreatic ducts near islets in transgenic mice. Pancreas 2008;37:e39-44.
27. Hingorani SR, Petricoin EF, Maitra A, et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003;4:437-450 (Pubitemid 38050041)
28. Aguirre AJ, Bardeesy N, Sinha M, et al. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev 2003;17:3112-3126 (Pubitemid 38040774)